Managing Director
and access,
Chris Nardo Focuses on transactions in private companies, primarily focused on raising capital for companies across the healthcare sector from Series A stage to crossover rounds. Prior to joining LifeSci Capital, Chris led the non-deal roadshow team at The Ruth Group for five years where he focused on investor targeting and outreach for companies in the healthcare space. Chris began his career at Angelo Gordon & Co. as a junior analyst. He graduated from Hofstra University with a BBA in Finance, Concentration in pre-med and a Minor in Chemistry. Chris holds a Series 63, 7 & 79.
